Xin Lang Cai Jing·2025-08-15 00:41Core Viewpoint - Junshi Biosciences (01877) announced that Shanghai Tanying Investment Partnership (Limited Partnership) plans to reduce its shareholding in the company through block trading due to fund duration and liquidity arrangements, with a maximum reduction of 20.53 million shares, accounting for no more than 2% of the company's total share capital [1] Group 1 - Shanghai Tanying is a private fund registered with the Asset Management Association of China and has successfully applied for the special regulations on share reduction for venture capital fund shareholders of listed companies [1] - The planned reduction will occur within three months after 15 trading days from the date of this announcement, with the total number of shares reduced in any consecutive 60 days not exceeding 2% of the company's total share capital [1]